GlassScriptPhysician profile
Helen Kim
NPI 1982220943
$10,053.19
in general payments reported to CMS, 2019-2025
13 companies · $1,005 in 2025
The $1,005 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $187 · 2021: $357 · 2022: $460 · 2023: $3,904 · 2024: $4,141 · 2025: $1,005.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,532 · Food and Beverage: $4,517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,531.96 |
| Food and Beverage | $4,517.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $7,375.56 | 2020-2025 | Ams 700, General - Erectile Dysfunction, Lithovue |
| Baxter Healthcare | $706.88 | 2020-2024 | Perclot, Floseal, Tisseel |
| Calyxo, INC. | $612.39 | 2024-2025 | Cvac Aspiration System |
| Coloplast Corp | $459.77 | 2024 | |
| Astellas Pharma US INC | $264.98 | 2021-2022 | |
| Endo USA, INC. | $162.00 | 2025 | Xiaflex, Aveed |
| Janssen Scientific Affairs, LLC | $144.24 | 2024 | Erleada |
| Teleflex LLC | $137.53 | 2023 | Urolift |
| Karl Storz Endoscopy-America | $83.75 | 2023-2024 | N.A., Flex-X |
| Acell, INC. | $50.09 | 2020 | |
| Myriad Genetic Laboratories, INC. | $20.00 | 2023 | Prolaris |
| Solventum Corporation | $18.84 | 2024 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Palette Life Sciences, INC. | $17.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helen Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.